|
Symbol
|
RMBQ5V | KZEHDU | KZFDDU | KZJVDU | RMBAIV | ACMVSQ | ADAATQ | LAGLDU | LALBDU | RMAY9V | ADXETQ | LAUJDU | 1129BC | AEEBTQ | Z0BIGZ | AEACTQ | LAYIDU | AENOTQ | AEHHTQ | LBDPDU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible |
|
Underlying
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly / Johnson & Johnson / Pfizer | Bayer AG / Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Intuitive Surgical Inc. / Merck & Co. Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) | Bayer AG / Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
17.11.2026 | 20.11.2026 | 30.11.2026 | 30.12.2026 | 30.12.2026 | 23.11.2026 | 27.11.2026 | 07.12.2026 | 02.07.2027 | 14.01.2027 | 12.02.2027 | 01.03.2027 | 05.03.2027 | 08.12.2026 | 09.03.2027 | 16.03.2027 | 17.03.2027 | 07.04.2027 | 14.01.2027 | 22.04.2027 |
| Bid | 35.630 | 34.550 | - | 32.750 | 44.400 | 63.67 | 60.73 | - | - | 58.70 | 101.28 | 97.80 | 92.81 | 95.94 | - | 95.78 | - | 91.86 | 89.14 | 94.80 |
| Ask | - | 35.550 | - | - | - | - | - | - | - | - | 102.09 | 98.80 | 93.55 | - | - | 96.58 | - | 92.66 | - | 95.80 |